Risk assessment in hypertrophic cardiomyopathy

Comment

R C Saumarez. Heart. 2009 Mar.

. 2009 Mar;95(5):421; author reply 421.

No abstract available

Comment on

Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice.
Elliott P, Spirito P. Elliott P, et al. Heart. 2008 Oct;94(10):1269-75. doi: 10.1136/hrt.2008.154385. Epub 2008 Jul 24. Heart. 2008. PMID: 18653582 Review.

Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Slade AK, Camm AJ. Slade AK, et al. Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:37-49. Arch Mal Coeur Vaiss. 1996. PMID: 8734163 Review.
Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
Limongelli G, Elliott PM, Pacileo G, Sarubbi B, Thaman R, Calabrò P, Vergara P, Iacomino M, Russo MG, Calabrò R. Limongelli G, et al. J Cardiovasc Med (Hagerstown). 2006 Sep;7(9):711-3. doi: 10.2459/01.JCM.0000243007.97793.0f. J Cardiovasc Med (Hagerstown). 2006. PMID: 16932087
Sudden cardiac death in athletes.
Tripathi BK, Gupta B, Agarwal AK. Tripathi BK, et al. J Assoc Physicians India. 2001 Jun;49:643-9. J Assoc Physicians India. 2001. PMID: 11584942 Review. No abstract available.
Risk assessment in hypertrophic cardiomyopathy.
Ward D. Ward D. Heart. 2009 Mar;95(5):421; author reply 421. Heart. 2009. PMID: 19218266 No abstract available.
Sudden cardiac death in young athletes.
Leikin SM, Pierce A, Nelson M. Leikin SM, et al. Dis Mon. 2013 Mar;59(3):97-101. doi: 10.1016/j.disamonth.2012.12.005. Dis Mon. 2013. PMID: 23410670 Review. No abstract available.